Alnylam Pharmaceuticals Inc Earnings

Healthcare · Biotechnology
Beat Rate
80.0%
4/5 quarters
Last EPS
$1.51
Estimate
$0.96
Surprise
+0.55
Last Report
2026-03

Upcoming Reports

Report Date Period EPS Est. Revenue Est.
Wed, Jul 29, 2026 2026-06 $1.63 $1.3B

Earnings History

Period Report Date EPS Est. EPS Actual Surprise Result
2026-03 $0.96 $1.51 +0.55 Beat
2025-12 $1.15 $0.82 -0.33 Miss
2025-09 $0.76 $2.11 +1.35 Beat
2025-06 $-0.73 $-0.51 +0.22 Beat
2025-03 $-1.03 $-0.44 +0.59 Beat

EPS Track Record

80.0% Beat Rate
Beats
4
Misses
1
Total reported
5